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Introduction
A balance between synthesis and decay determines the steady-
state level of mRNA. For most mRNAs, synthesis and decay 
take place in different cellular compartments, and little is known 
about cross talk between these two processes.
The yeast RNA polymerase II (Pol II) is composed of 
12 subunits termed Rpb1p-Rpb12p (Young, 1991). The crystal 
structure of yeast Pol II reveals that the enzyme comprises two 
distinctive parts (Armache et al., 2003; Bushnell and Kornberg, 
2003); a ten-subunit core carrying the catalytic active site and 
a two-subunit heterodimer composed of Rpb4p and Rpb7p (for 
review see Choder, 2004; Sampath and Sadhale, 2005). Rpb7p 
is an essential Pol II subunit that is conserved from archea to 
humans (McKune et al., 1993; Mitsuzawa et al., 2003; Choder, 
2004). It carries two highly conserved RNA binding domains 
(Todone et al., 2001; Armache et al., 2005; Meka et al., 2005) 
that likely bind RNA cooperatively (Todone et al., 2001). In vitro 
studies indicate that Rpb7p can bind RNA in a sequence-
independent fashion (Orlicky et al., 2001; Meka et al., 2003, 2005). 
Importantly, Rpb7p interacts with a transcript during in vitro tran-
scription as soon as the latter emerges from the Pol II core (Ujvari 
and Luse, 2006). Therefore, Rpb7p is most likely among the fi  rst 
proteins to interact with nascent Pol II transcripts.
Unlike Rpb7p, Rpb4p is a nonessential protein (Woychik 
and Young, 1989; Choder and Young, 1993; Rosenheck and 
Choder, 1998). Notably, Rpb4p is involved in mRNA export from 
the nucleus to the cytoplasm only during stress (Farago et al., 
2003) and plays a direct role in cytoplasmic degradation of a 
specifi  c class of mRNAs encoding protein biosynthetic factors 
(PBFs) (Lotan et al., 2005). PBFs include ribosomal proteins, 
translation initiation factors, aminoacyl tRNA synthetases, and 
ribosomal biosynthetic proteins. Because cells can proliferate in 
the absence of RPB4, it is clear that the indispensable Rpb7p 
can function independently of Rpb4p and can interact with Pol II 
in the absence of Rpb4p (Sheffer et al., 1999). However, it is not 
known whether Rpb7p plays a role outside Pol II context.
In yeast, major pathways of mRNA degradation (for 
review see Coller and Parker, 2004; Amrani et al., 2006; Garneau 
et al., 2007) initiate with shortening of the mRNA poly(A) tail. 
When the length of the poly(A) tail reaches 10–12 bases or less, 
one of two alternative pathways is initiated (or both pathways are 
initiated simultaneously). One pathway involves removal of the 
mRNA 5′ cap [m(7)GpppN] by the Dcp1p/Dcp2p heterodimer 
The Rpb7p subunit of yeast RNA polymerase II 
plays roles in the two major cytoplasmic mRNA 
decay mechanisms
Rona Lotan, Vicky Goler-Baron, Lea Duek, Gal Haimovich, and Mordechai Choder
Department of Molecular Microbiology, Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa 31096, Israel
T
he steady-state level of mRNAs is determined by the 
balance between their synthesis by RNA polymerase II 
(Pol II) and their decay. In the cytoplasm, mRNAs 
are degraded by two major pathways; one requires de-
capping and 5′ to 3′ exonuclease activity and the other 
involves 3′ to 5′ degradation. Rpb7p is a Pol II subunit 
that shuttles between the nucleus and the cytoplasm. Here, 
we show that Rpb7p is involved in the two mRNA decay 
pathways and possibly couples them. Rpb7p stimulates 
the deadenylation stage required for execution of both 
pathways. Additionally, Rpb7p is both an active component 
of the P bodies, where decapping and 5′ to 3′ degradation 
occur, and is capable of affecting the P bodies function. 
Moreover, Rpb7p interacts with the decapping regulator 
Pat1p in a manner important for the mRNA decay ma-
chinery. Rpb7p is also involved in the second pathway, as 
it stimulates 3′ to 5′ degradation. Our genetic analyses 
suggest that Rpb7p plays two distinct roles in mRNA 
decay, which can both be uncoupled from Rpb7p’s role in 
transcription. Thus, Rpb7p plays pivotal roles in determining 
mRNA levels.
R. Lotan and V. Goler-Baron contributed equally to this paper.
Correspondence to Mordecai Choder: choder@technion.ac.il
Abbreviations used in this paper: HS, heat shock; mRNP, mRNA-proteins 
complex; PB, processing body; PBF, protein biosynthetic factor; Pol II, RNA 
polymerase II; ts, temperature sensitive; WT, wild type.
The online version of this article contains supplemental material.JCB • VOLUME 178 • NUMBER 7 • 2007  1134
(Decker and Parker, 1993; Dunckley and Parker, 1999; Liu and 
Kiledjian, 2006). Several proteins regulate this decapping pro-
cess, including Pat1/Lsm1-7 (Boeck et al., 1998; Bonnerot et al., 
2000; Bouveret et al., 2000; Tharun et al., 2000). Pat1p is re-
cruited to mRNA while it is still associated with translation fac-
tors (Tharun and Parker, 2001). Subsequently, Pat1p recruits the 
hepta-heterodimer Lsm1-7 complex and this event is associated 
with the transition from translation to decay (Tharun and Parker, 
2001; Coller and Parker, 2004). In vitro, Pat1-Lsm1-7 complex 
binds at or near the 3′ end of the mRNA (Chowdhury et al., 
2007) and is cable of protecting the 3′ ends of mRNAs in vivo 
from trimming (He and Parker, 2001). The deadenylated mRNA 
can be degraded by alternative pathway that degrades the mRNA 
from its 3′ terminus. A well-studied 3′ to 5′ exonuclease is a 
large complex known as exosome (for review see Houseley et al., 
2006). The relative contribution of each mechanism remains a 
subject of debate. In Saccharomyces cerevisiae, knocking out 
components of either the 3′ to 5′ (Houalla et al., 2006) or the 5′ 
to 3′ pathway (He et al., 2003) had minimal effects on the tran-
scriptome, which implies tight regulation of mRNA level involv-
ing cross talk between the two decay mechanisms. Nonetheless, 
very little is known about any possible dialogue between the two 
decay mechanisms.
Recently, we proposed that Rpb4p is the fi  rst mRNA decay 
factor to be recruited to mRNA in the nucleus. After transport of 
the mRNP to the cytoplasm, Rpb4p is involved in recruiting the 
Pat1/Lsm1-7 complex, or stimulating Pat1/Lsm1-7 function, 
and stimulates mRNA decay (Lotan et al., 2005). However, be-
cause Rpb4p does not have an RNA-binding domain (Todone 
et al., 2001; Armache et al., 2005; Meka et al., 2005), it was not 
clear how this protein is recruited to the mRNP.
Here, we report novel functions for Rpb7p in the two cyto-
plasmic mRNA decay pathways. Mutation analyses reveal the 
existence of temperature-sensitive (ts) Rpb7ps that are tran-
scriptionally functional but fail to stimulate mRNA decay. We 
have identifi  ed mutant forms of Rpb7p that are specifi  cally de-
fective in only one of their three functions, raising the possibil-
ity that the three functions are distinct. Further genetic analyses 
suggest that Rpb7p functions in the context of Rpb4/7. Never-
theless, whereas Rpb4p plays a role in the decay of specifi  c 
mRNAs, Rpb7p has a more general role in the mRNA decay 
pathway. Collectively, our observations suggest that the Rpb4/7 
is involved in a cross talk between the two cytoplasmic mRNA 
decay mechanisms and between the nuclear and cytoplasmic 
stages of gene expression.
Results
Rpb7p is localized in cytoplasmic P bodies
Previously we have shown that Rpb7p shuttles between the 
nucleus and the cytoplasm by a transcription-dependent mecha-
nism. Moreover, Rpb7p shuttles as a heterodimer together with 
Rpb4p (Selitrennik et al., 2006), which plays a role in the cyto-
plasmic mRNA decay pathway (see Introduction). In addition, 
we observed that Rpb7p-GFP localizes in discrete foci that re-
semble processing bodies (PBs) (Selitrennik et al., 2006), the site 
where decapping and degradation of mRNAs occurs (Ingelfi  nger 
et al., 2002; Lykke-Andersen, 2002; van Dijk et al., 2002; Sheth 
and Parker, 2003; Teixeira et al., 2005). These observations 
prompted us to investigate whether Rpb7p is involved in mRNA 
decay. To determine the nature of Rpb7p cytoplasmic foci, we 
examined whether known PB proteins colocalize in these areas. 
Indeed, two PB markers (Sheth and Parker, 2003; Brengues et al., 
2005), RFP-tagged Dcp2p (Fig. 1 A) and Lsm1-RFP (unpub-
lished data), colocalize with Rpb7p-GFP. Colocalization was ob-
served in response to starvation and ranges between 10 and 60% 
of the cases, depending on the strain background and on the envi-
ronmental conditions. Rpb7p-GFP foci were also colocalized 
with Rpb4-RFP foci that were recently shown to represent PBs 
(Lotan et al., 2005). Moreover, like genuine PBs, Rpb7p-GFP 
foci disappear in response to pretreatment with the translation 
inhibitor cyclohexamide (Fig. 1). These results confi  rm our suspi-
cion that Rpb7p is localized in PBs and raise the possibility that 
Rpb7p is involved in the deadenylation-dependent mRNA decay 
that takes place there.
Mutations in RPB7 compromise the decay 
of PBF and non-PBF mRNAs
To determine more directly whether Rpb7p is involved in mRNA 
decay, we mutagenized randomly the essential RPB7 gene and 
selected ts alleles (see Materials and methods). Consistent with 
previous results (Zaros and Thuriaux, 2005), we could not iden-
tify ts alleles that carry only one mutation. We selected 13 ts 
mutants that carry 2–6 point mutations (see Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb. 200701165/DC1). 
The mutations are scattered throughout the proteins, suggest  ing 
that the overall conformation of this small protein is   important 
Figure 1.  Rpb7p-GFP colocalizes with Dcp2p-RFP in PBs. Cells expressing 
RPB7-GFP and DCP2-RFP (yRL11) and cells expressing RPB7-GFP and 
RPB4-RFP (yMS8) were starved and then visualized microscopically, as de-
scribed previously (Lotan et al., 2005). +CHX panels, cyclohexamide-
treated cells (Lotan et al., 2005).RPB7P FUNCTIONS IN 5′-3′ AND IN 3′-5′ MRNA DECAY • LOTAN ET AL. 1135
for its function. First, we determined the transcriptional capac-
ity of the ts mutants at their nonpermissive temperature by 
monitoring de novo synthesis of various heat-shock (HS) mRNAs 
in response to abrupt HS. As expected for an essential pol II 
subunit, some of the 13 mutants exhibit transcriptional defects 
at nonpermissive temperatures (Fig. S2; rpb7-29). Notably, 
however, some of the mutants do not exhibit diminished tran-
scription capacity (Fig. S2; rpb7-26 and rpb7-28). Consistently, 
levels of these mutant forms of Rpb7p, as detected by Western 
analysis, are comparable to that of the wild-type (WT) Rpb7p 
(unpublished data). Yet, these mutants are ts. These results suggest 
that Rpb7p has an essential posttranscriptional role(s) at 37°C. 
Moreover, because the levels of HS mRNAs in the transcrip-
tionally functional ts mutants are higher than in WT, these data 
support the premise that the essential posttranscriptional role of 
Rpb7p is in mRNA decay. It is worth noting that although most 
mRNA decay factors are nonessential at 30°C, some of them 
become essential at high temperatures (Coller and Parker, 2004; 
Parker and Song, 2004).
Therefore, we determined whether any of the ts mutants 
exhibit defects in mRNA degradation. To monitor mRNA decay, 
transcription was blocked either synthetically by adding 1, 10, 
phenanthroline (Fig. 2, A and B) or naturally by shifting cells 
from 30°C (our standard permissive temperature) to 42°C (Fig. 
2 C). The latter method relies on physiological responses to HS, 
which comprises aborting transcription of non-HS genes and 
enhancing decay of non-HS mRNAs (Lotan et al., 2005; see also 
Fig. 2, A and B). Using this HS assay, which simultaneously 
  inactivates the ts Rpb7p and blocks transcription, we found that 
50% of the ts mutants exhibit detectable defects in the decay 
of YEF3 and TIF1 mRNAs (unpublished data). We analyzed in 
more detail yRL26, yRL28, yRL29, and yRL34 strains (carrying 
rpb7-26, rpb7-28, rpb7-29, and rpb7-34 ts alleles, respectively), 
which show the most severe defects in mRNA decay.
Next, we examined whether the mutant strains are defec-
tive in mRNA decay at 37°C, instead of 42°C. Because at 37°C 
transcription is not blocked, we monitored decay of Tet-Off-
MFA2pG transcript after blocking transcription by doxycycline. 
As shown in Fig. S3 (available at http://www.jcb.org/cgi/content/
full/jcb.200701165/DC1), the initial decay of MFA2 mRNA was 
similar in both strains. However, after 25 min post-temperature 
shift-up, mRNA degradation was slower in the mutant as com-
pared to its degradation in the WT. This behavior shows that, 
already at 37°C, mRNA decay is defective in the mutant cells, but 
raises the possibility that inactivation of Rpb7p ts at 37°C was 
delayed and requires  25 min. In our subsequent analyses we 
monitored mRNA stability at 42°C, as discussed below.
To systematically examine mRNA decay in our mutant 
strains, we fi  rst examined mRNA turnover at the permissive 
temperature. At 30°C, decay kinetics in the mutants are compa-
rable to those in WT (Fig. 2 A; unpublished data). In agreement 
with this, at the permissive temperature the steady-state levels of 
various mRNAs in all our mutant strains are comparable to 
those in WT. In contrast, at 42°C, the mutants exhibit defective 
decay (Fig. 2, B and C). This defect is observed independently 
of the method that was used to block transcription (compare 
Fig. 2 B with Fig. 2 C; and unpublished data). Importantly, at 42°C, 
Figure 2.  PBF and non-PBF mRNAs decay abnormally slowly at the non-
permissive temperature in rpb7 ts mutants. (A) At the permissive tempera-
ture, rpb7-29 and WT exhibit similar mRNA decay kinetics. The indicated 
strains were proliferated at 30°C until mid-log phase. 1, 10, phenanthro-
line was added to block transcription (Grigull et al., 2004; Lotan et al., 
2005). Decay kinetics was determined by monitoring mRNA levels at the 
indicated time points post-transcription block, using Northern analysis with 
the indicated probes. rRNA serves to demonstrate equal loading. Half-lives 
(designated T1/2) were determined as described previously (Lotan et al., 
2005) and the ratios between T1⁄2 of the mutant and that of the wild-type 
[T1⁄2 (m)/T1⁄2 (WT)] are indicated on the right. Lengths of the open reading 
frames are indicated in parentheses next to the gene name on the left. (B) At 
the nonpermissive temperature, rpb7-29 cells exhibit defective mRNA 
decay. Cells were challenged simultaneously with 1, 10, phenanthroline 
and shifted to 42°C and mRNA decay was determined as in A. (C) rpb7-28 
cells are defective in mRNA decay. Cells were proliferated at 30°C till 
mid-log phase and then shifted abruptly to 42°C (no drug was added). 
The high temperature led both to inactivation of Rpb7-28p ts and to tran-
scription arrest (Lotan et al., 2005). mRNA decay was determined as in A. 
(D) Decay kinetics of YEF3 mRNA in WT and rpb7-28 cells was determined 
as described previously (Lotan et al., 2005).JCB • VOLUME 178 • NUMBER 7 • 2007  1136
the mutants exhibited defective decay as soon as cells were 
shifted to the high temperature (Fig. 2, B and C). A good example 
for rapid inactivation of Rpb7 ts is the decay of NSR1 mRNA, 
which becomes very unstable at 42°C (Lotan et al., 2005). Already 
5 min after the temperature shift, more mRNA is observed in 
the mutant than in the WT (Fig. 2 B, NSR1). A quantitative ex-
ample is the decay of YEF3 (Fig. 2, C and D).
Rpb4p is specifi  cally involved in the decay of PBF mRNAs 
(see Introduction). Unlike Rpb4p, mutations in Rpb7p affect the 
decay of both PBF and non-PBF mRNAs. Among the non-PBF 
mRNAs are short-lived mRNAs, such as MFA2 and ACB1 (see 
Fig. 3) and GPP1 mRNAs, as well as relatively stable mRNAs, 
such as ACT1 mRNA (Fig. 2 C). Thus, it appears that the role 
of Rpb7p in mRNA decay is more general than that of Rpb4p 
(see Discussion).
Rpb7p stimulates deadenylation
To gain insight into the mechanism by which Rpb7p functions 
in the major mRNA decay, we examined what step(s) in mRNAs 
turnover is/are stimulated by Rpb7p. Cells were shifted to 42°C 
to inactivate both transcription and the function of Rpb7p ts 
form, and then the levels and poly(A) tail lengths of RPL29 and 
RPL25 mRNAs were monitored using the polyacrylamide gel 
electrophoresis Northern (PAGEN) technique (Sachs and Davis, 
1989), as shown in Fig. 3. These mRNAs were chosen because 
their short length enables detection of small differences in the 
size of their poly(A) tail. Three conclusions can be made con-
cerning the results shown in Fig. 3. First, the decay kinetics of 
these mRNAs is fast in WT cells and slower in mutant cells, 
consistent with our results obtained by standard Northern analy-
sis shown in Fig. 2. Second, deadenylation is abnormally slow in 
the mutant cells. For example, whereas complete deadenylation 
of RPL29 mRNA is observed in WT after 45 min (Fig. 3, lane 5), 
it takes 70 min for this to occur in rpb7-28 (Fig. 3, lane 13). 
We conclude that Rpb7-28p is defective in stimulating rapid 
deadenylation. As shown in Fig. 3, after its complete deadenyl-
ation 25 min post-transcription arrest, it is only a further 20 min 
before RPL25 mRNA is almost completely degraded in WT 
(between 25 to 45 min post-transcription arrest; see lanes 4 and 5). 
In contrast, to degrade comparably the deadenylated RPL25 
mRNA in rpb7-28 takes 75 min (lanes 12–14). A third conclusion, 
then, is that Rpb7p stimulates not only deadenylation, but also 
post-deadenylation step.
In summary, our data support a dual function for Rpb7p 
in mRNA decay. Rpb7p both accelerates deadenylation and 
stimulates a post-deadenylation step. The nature of the post-
deadenylation step is discussed in the next section.
Mutations in RPB7 can lead to defective 
execution of the 3′ to 5′ pathway 
of mRNA degradation
The major post-deadenylation step that is defective in rpb7-28 
cells might be either decapping or 5′ to 3′ degradation or 3′ to 
5′ degradation of the decaying mRNA (Coller and Parker, 2004; 
Amrani et al., 2006; Garneau et al., 2007). To distinguish 
between these processes we took advantage of a construct 
designed to identify degradation intermediates. Specifically, 
a previous study has revealed that a (G)18 tract, placed in the 
3′ UTR of MFA2 mRNA, serves as a barrier for exonuclease 
activity. Consequently, 5′ to 3′ degradation of MFA2pG mRNA by 
Xrn1p produces a  190-  base degradation intermediate frag-
ment (Fig. 4, “Frag.”) that stretches from the poly(G) tract to the 
3′ end (Vreken and Raue, 1992; Decker and Parker, 1993). This 
fragment can be degraded by the 3′ to 5′ pathway (Anderson 
and Parker, 1998). Because Xrn1p degrades only uncapped RNA, 
accumulation of this intermediate is usually indicative of 
effi  cient decapping (Hatfi  eld et al., 1996; Dunckley and Parker, 
1999; Tharun et al., 2000, 2005). We introduced Tet-Off-
MFA2pG in WT and rpb7-28 cells and used this assay to deter-
mine which post-deadenylation step is defective in the mutant 
cells. As shown in Fig. 4 A, fragment level relative to the full-
length mRNA is threefold higher in rpb7-28 cells than it is in 
wild-type cells. Because the fragment is degraded by 3′ to 5′ 
Figure 3.  Rpb7p is required for efﬁ  cient deadenylation and subsequent 
decay of both PBF and non-PBF mRNA. Cells were shifted rapidly to 42°C 
to block transcription and to inactivate the ts Rpb7-28p. RNA was   extracted 
at the indicated time points post-shift and analyzed by the polyacrylamide 
Northern technique (Sachs and Davis, 1989). The same membrane was 
hybridized sequentially with the indicated probes. Actual lengths (relative 
to size marker) of the indicated mRNAs (without the poly(A) tail) are indi-
cated in parentheses next to the gene name on the left. Lane “∆(A)n” shows 
the position of fully deadenylated RNA. This RNA was obtained by hybrid-
izing RNA sample from time point 0 with oligo(dT), followed by digestion 
of the poly(A) tail by RNase H. The star indicates the time point when 
deadenylation seems to be complete. We suspect that in some cases 
  complete deadenylation occurred in between two time points. In these 
particular cases, the star is placed between lanes. SCR1 RNA (a Pol III 
transcript) serves to demonstrate equal loading.RPB7P FUNCTIONS IN 5′-3′ AND IN 3′-5′ MRNA DECAY • LOTAN ET AL. 1137
exonuclease (Anderson and Parker, 1998), high fragment level 
is often indicative of effi  cient decapping and poor 3′ to 5′ exo-
nuclease activity.
To examine if 3′ to 5′ decay is defective in rpb7 mutants, 
we fi  rst took advantage of a genetic assay based on the  observa-
tion that strains lacking both the major deadenylation and the 
alternative 3′ to 5′ are inviable (Anderson and Parker, 1998; 
van Hoof et al., 2000). Thus, any double-mutant that contains 
a block to the 5′ decay pathway (xrn1∆) with a block to the 
3′ decay pathway (e.g., ski2∆, ski3∆) is synthetically lethal 
(Anderson and Parker, 1998). The synthetic relationship between 
XRN1 and rpb7 ts mutants is shown in Fig. 4 B. rpb7-26 can re-
place RPB7 in xrn1∆ cells. This result indicates that cells lack-
ing XRN1 and carrying rpb7-26 as the only source of Rpb7p can 
support 3′ to 5′ decay. In contrast, rpb7-29 cells and rpb7-34 
cells cannot survive in the absence of XRN1. rpb7-28 cells pro-
liferate very slowly without XRN1 (Fig. 4 B), consistent with 
the abnormal accumulation of the MFA2pG fragment (Fig. 4 A). 
Figure 4.  Rpb7p is required for efﬁ  cient execution of the 3′ to 5′ degradation of MFA2pG mRNAs. (A) rpb7-28 cells contain high level of MFA2pG degra-
dation intermediate. WT and rpb7-28 cells expressing Tet-Off-MFA2pG (yVB32 and yVB34) were harvested in mid-log phase. MFA2pG mRNA (designated 
F.L.) and its degradation intermediate fragment (designated Frag.) were examined using PAGE Northern technique as in Fig. 3, except that electrophoresis 
was shorter to allow detection of the fragment. MFA2pG-speciﬁ  c probe was used (see Materials and methods). As a control for the probe speciﬁ  city, RNA 
from cells lacking the plasmid was also analyzed (“No plasmid” lane). SCR1 RNA (a Pol III transcript) serves to demonstrate equal loading. The ratio be-
tween the fragment radioactivity and that of the full length was obtained by PhosphorImager technology and is indicated at the bottom. (B) Deletion of XRN1 
displays synthetic lethality in combination with rpb7-29 and rpb7-34, synthetic sickness in combination with rpb7-28, but not with rpb7-26. A strain lacking 
XRN1 and carrying pRPB7::URA3 in lieu of RPB7 (yMC414) was transformed with HIS3 plasmid carrying RPB7 or rpb7 mutants as indicated on the left. 
Synthetic lethality assay was performed as described in Materials and methods. In parallel, cells were spotted on a plate lacking 5-FOA (SC lacking histidine), 
designated “non-selective medium”, to demonstrate spotting of equal number of cells. (C) rpb7-29 cells are defective in 3′ to 5′ exonuclease activity. 
WT and rpb7-29 cells were grown to mid-log phase at 30°C. 2 μg/ml doxycycline was added to block transcription of Tet-Off-MFA2pG mRNA. Immediately 
thereafter, 100 μg/ml cyclohexamide was added in order to block decapping and consequently block Xrn1p activity. Immediately thereafter, cells were 
shifted to 37°C and samples were harvested at the indicated time points and their RNAs were analyzed by PAGE Northern as in A. Lane designated 
“No plasmid” used as a control as in A. SCR1 RNA was used for normalization. Short exposure of the membrane is shown in the top autoradiogram. 
Longer exposure of the fragment is shown in the bottom autoradiogram, for better detection. (D) 3′ to 5′ decay kinetics of the fragment. Fragment level was 
monitored by PhosphorImager, normalized to that of SCR1 RNA, and plotted as a function of time post-transcription and decapping block. A band intensity 
at time 0 was deﬁ  ned as 100%, and intensities at other time points were calculated relative to time 0. Similar results were obtained by four hybridization 
analyses. Variations were 15%.JCB • VOLUME 178 • NUMBER 7 • 2007  1138
These results suggest that, indeed, Rpb7p is required for execu-
tion of the 3′ to 5′ decay pathway, and that some of our mutants 
are defective in this function. Interestingly, the synthetic lethal-
ity was observed at 30°C, suggesting that the mutants are defec-
tive in 3′ to 5′ decay at the permissive temperature.
To corroborate the synthetic lethality results biochemi-
cally, we introduced pTet-Off-MFA2pG in rpb7-29 cells, which 
showed the most severe synthetic lethality, and determined the 
fragment stability. To this end, we blocked transcription of 
Tet-Off-MFA2pG by doxycycline and simultaneously blocked 
decapping (and hence Xrn1p capacity to act) by cyclohexamide 
(Beelman and Parker, 1994) while shifting cells to the non-
permissive temperature. These two inhibitors blocked supply of 
new fragments, permitting us to follow 3′ to 5′ decay of the 
fragment that had preexisted in the cytoplasm (because it is a 
product of Xrn1p that acts in the cytoplasm) prior drugs addition 
(Anderson and Parker, 1998; Boeck et al., 1998; Araki et al., 
2001). Whereas in WT cells the fragment is rapidly degraded 
(t1/2 = 30 min), no degradation can be detected throughout the 
experiment duration (Fig. 4 C and D). Thus, the 3′ to 5′ decay 
mechanism is defective in the mutant cells. In rpb7-26 cells, 
which do not show synthetic lethality with XRN1 (Fig. 4 B), the 
fragment half-life was 30 min (unpublished data). Note that in 
rpb7-29 cells, the steady-state level before the temperature shift 
(time 0) is not higher than it is in WT cells (unlike the case of 
rpb7-28 cells). It is possible that Rpb7-29 is also defective in 
  decapping. Collectively, the results shown in Fig. 4 indicate that 
Rpb7p is required for effi  cient 3′ to 5′ degradation of mRNAs.
Rpb7p is involved in PB function
Previously it was shown that mutations in some mRNA decay 
factors impact the number of PBs (Sheth and Parker, 2003; Cougot 
et al., 2004; Kshirsagar and Parker, 2004; Coller and Parker, 
2005; Anderson and Kedersha, 2006). The novel roles of Rpb7p 
in mRNA decay and its localization to PBs (Fig. 1) prompted us 
to examine whether mutations in RPB7 similarly affect PB num-
ber, using Dhh1p-GFP or Pat1p-GFP as the PB marker (Sheth 
and Parker, 2003). As expected, at the permissive temperature 
when Rpb7p ts forms function normally (see Fig. 2), PBs are 
readily detected in both WT and mutant cells (Fig. 5; 30°C). 
To rapidly inactivate the ts Rpb7p, we exposed cells to non-
permissive temperatures (42°C) for 45–60 min before visualizing 
them microscopically. In response to temperature increase of 
WT cells, the number (and size) of PBs decreases (Fig. 5; WT). 
Thus, PBs respond to HS differently than they respond to some 
other stress conditions. Specifi  cally, during starvation and other 
stresses, the number (and size) of PBs increases because mRNA 
decay is repressed (Teixeira et al., 2005). However, during HS, 
mRNA decay is not repressed (see Fig. 2 C). Moreover, because 
both transcription initiation (see Fig. 2 C) and translation initia-
tion (Holcik and Sonenberg, 2005) are repressed at high temper-
atures, there is no new supply of mRNPs to PBs. Consequently, 
at least one mechanism for disassembly of PBs during HS is 
mRNA degradation. In contrast with WT, no decrease in the 
number (and size) of PBs is observed in the rpb7 ts mutant in 
this time frame (Fig. 5). These results indicate that Rpb7p is an 
active component of PBs. They are consistent with the defective 
mRNA degradation that characterizes rpb7 mutants at nonper-
missive temperatures, as such a defect is likely to result in more 
mRNA molecules remaining in PBs after the temperature in-
crease and hence less dissociation of PBs.
Genetic and two-hybrid interactions 
between RPB7 and genes encoding 
components of the Pat1/Lsm1-7p complex
We have shown previously that Pat1p can be immunoprecipitated 
with Rpb4p and Rpb7p (Lotan et al., 2005). To corroborate the 
interaction between Rpb7p and Pat1p by other means, we used 
both genetic and two-hybrid approaches. Taking advantage of the 
temperature sensitivity (ts) of pat1∆ cells (Bonnerot et al., 2000; 
He and Parker, 2001), we determined whether overexpression of 
Figure 5.  RPB7 affects the P bodies’ number. Wild-type cells and their iso-
genic rpb7 ts derivatives, expressing DHH1-GFP (A and C) or PAT1-GFP (B) 
(see Table I), were allowed to proliferate at 30°C in a selective medium 
  until late-log phase. Cultures were then shifted to 42°C for 45 min (A) or 
60 min (B). Cells were washed 3 with water before they were visualized 
by ﬂ  uorescent microscopy. (C) Average number of DHH1-GFP PBs per cell. 
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RPB7 and RPB4 could suppress this phenotype. Overexpression 
of RPB4 has a small, yet signifi  cant, suppression effect on the ts 
phenotype of pat1∆ (Lotan et al., 2005). In contrast, overexpres-
sion of RPB7 enhances the proliferation defect at of pat1∆ cells 
36°C, but has little effect on proliferation of WT cells (Fig. 6 A). 
We also evaluated the consequence of co-overexpressing both 
RPB4 and RPB7, including their own 5′ and 3′ noncoding regu-
latory sequences, on the same high copy plasmid. Overexpress-
ing both genes in this way suppresses the proliferation defect of 
pat1∆ more substantially than overexpressing RPB4 alone (Fig. 
6 A). The genetic interaction between RPB7 and PAT1 supports 
our conjecture that their products share a similar biochemical 
pathway and that Rpb7p plays a direct role in the major mRNA 
decay pathway that involves Pat1p. The synergistic suppression 
effect of simultaneously over-producing both Rpb4p and Rpb7p 
suggests that they interact optimally with Pat1p in the context of 
the Rpb4/7 heterodimer. Consistent with this possibility, we found 
that rpb7 ts alleles (including those that are defective only in 
mRNA decay), but not WT RPB7, are synthetically lethal with 
deletion of RPB4 (Fig. S4, available at http://www.jcb.org/cgi/
content/full/jcb.200701165/DC1). These results indicate that 
the mutant forms of Rpb7p require Rpb4p to carry out their 
 essential  function.
Two-hybrid analysis suggests that Rpb7p forms a direct 
contact with Pat1p (Fig. 6 B). In addition we examined two-
hybrid interaction between Rpb7p as the bait and, as prey, each of 
20 proteins known to be involved in the mRNA decay pathway 
(listed in the legend to Fig. 6 B). Only Pat1p exhibits a strong 
and reproducible interaction with Rpb7p. Lsm2p showed weak 
interaction as well (unpublished data).
To further study the mechanism by which Rpb7p func-
tions in mRNA decay, we evaluated the capacity of our Rpb7p 
ts mutants to interact with Pat1, using the two-hybrid assay. 
As shown in Fig. 6 C, the various mutant forms of Rpb7p that 
Figure 6.  Rpb7p interacts with Pat1p; the extent of interaction correlates with the capacity of Rpb7p to stimulate mRNA decay. (A) High copy effect of the 
indicated genes on the proliferation capacity of pat1∆ cells or their WT counterparts. Two strain backgrounds were examined. WT strain (yMC229) and 
its isogenic pat1∆ strain (yMC363) are designated “Strain A”; WT (yMC269) or its pat1∆ derivative yMC272 are designated “Strain B”. Cells carrying 
high copy plasmid expressing the indicated genes were spotted in ﬁ  vefold serial dilutions onto selective plates. Cells were allowed to grow at the non-
permissive temperature for pat1∆ cells, 36°C. (B) Two-hybrid interactions between Rpb7p as the bait and genes whose products are involved in mRNA de-
cay as prey were performed as described in Materials and methods. Only 6 of 20 genes tested are shown as indicated around the plate. The other genes 
that did not exhibit interactions with the Rpb7p-DBD and are not shown here are Lsm1p, Lsm3p–Lsm7p, Ccr4p, Not1p, Caf1p, Pan2p, Pan3p, Pop2p, 
Edc1p, Edc2p, Edc3p, and Pab1p. Lsm2p showed weak interaction (not depicted). Equal amount of cells, carrying the indicated prey plasmids, were 
streaked onto an indicator plate as described in Materials and methods. We then veriﬁ  ed that the growth on the indicator plates was dependent on both 
plasmids by evicting one plasmid at a time from the positive clones (not depicted). (C) Two-hybrid interaction between various mutant forms of Rpb7p-DBD 
and Pat1p-AD. Cells were spotted in threefold serial dilutions, starting with 10
6 cells/spot, on an indicator plate as in B (selective conditions). Plates were 
incubated for 3 d at the indicated temperatures. To demonstrate spotting of equal amounts of cells, cells were spotted on a nonselective plate that allowed 
growth of cells that carry both the bait and prey plasmids independently of the two-hybrid interactions (using medium lacking only leucine and tryptophane). 
β-galactosidase (β-Gal) values, quantitative means to determine interactions (Uetz et al., 2000), are indicated on the right. They reﬂ  ect the average values 
determined from two independent experiments (variations were 15%). Background values obtained with cells expressing only the bait plasmid were 
subtracted. Levels of the various mutant forms of Rpb7p-DBD were found to be comparable to that of the WT Rpb7-DBD (not depicted).JCB • VOLUME 178 • NUMBER 7 • 2007  1140
are defective in stimulating mRNA decay are also defective 
in interacting with Pat1p. This defect is more severe at 36°C than 
at 30°C. The liquid β-gal test, which examines an additional 
  reporter of the two-hybrid interaction (Uetz et al., 2000), yields 
similar results (Fig. 6 C). These data suggest that the defective 
capacity of Rpb7p mutant forms to stimulate mRNA decay is 
related to their poor binding of Pat1p.
Discussion
Rpb7p plays a direct role in two stages 
of the cytoplasmic mRNA decay process
RNA polymerase II is composed of two distinct structural do-
mains that can be readily dissociated from each other; one of 
them is the Rpb4/7 heterodimer. Thus, within the context of 
pol II, Rpb7p functions in concert with Rpb4p (Choder, 2004). 
Previously, we discovered that Rpb4p is involved in mRNA decay 
in the cytoplasm. Overexpression of Rpb7p could not suppress 
the defective capacity of rpb4∆ cells to support mRNA decay 
(Lotan et al., 2005), suggesting that Rpb4p has a distinct role in 
the decay of these mRNAs, which cannot be replaced by Rpb7p. 
Thus, an unresolved issue has been whether Rpb7p has any role 
in the decay pathway. Here, we show that Rpb7p plays key roles 
in mRNA decay.
We have uncovered two novel roles for Rpb7p in two 
major mRNA decay pathways. Thus, Rpb7p stimulates the de  -
ad  enylation stage required for execution of both pathways. Rpb7p 
is required for the major pathway via its interaction with Pat1/
Lsm1-7 complex (see below) and for effi  cient execution of the 
second pathway. These two functions can be uncoupled geneti-
cally as some Rpb7p mutant forms are defective and some 
are not defective in stimulating 3′ to 5′ decay (Fig. 4 B). We 
also identifi  ed a ts mutant that is not defective in stimulating de-
ad  enylation and is defective in supporting decay after deadenyl-
ation (unpublished data). Thus, Rpb7p plays distinct roles in 
either pathway and is probably involved in a cross talk between 
the two. Although it is quite possible that the two major decay 
pathways are linked, detailed mechanistic understanding of this 
possible cross talk remains to be determined.
Association of Rpb7p with the decaying mRNP might be 
important to maintain an appropriate RNP conformation, which 
is necessary for effi  cient execution of both pathways. Alterna-
tively, Rpb7p might play more direct roles in mRNA decay 
pathways. We maintain that, at least in the major pathway, Rpb7 
plays a direct role via its interaction with Pat1p and Lsm2p and 
its interaction with PBs (see below).
Consistent with its role in the major decay pathway, 
Rpb7p is a constituent of PBs. Moreover, defects in Rpb7p can 
affect the capacity of PBs to dissociate when cells are exposed 
to HS (which is also a nonpermissive temperature for rpb7 ts 
alleles). Thus, like some other known mRNA decay factors 
(Sheth and Parker 2003; Kshirsagar and Parker 2004), Rpb7p 
seems to be an active PB effector. In addition, we show here 
that Rpb7p interacts with components of the Pat1/Lsm1-7 
complex. Moreover, mutations in Rpb7p that compromise the 
capacity of Rpb7p to function in mRNA decay also diminish its 
capacity to interact with these components. All these data strongly 
suggest that Rpb7p plays a direct role in the major mRNA 
decay pathway.
As Rpb7p is both a nuclear and cytoplasmic protein, it is 
important to discern whether its role in mRNA decay is performed 
in the nucleus or in the cytoplasm. We contend that Rpb7p is 
involved in the cytoplasmic decay pathways for the following 
reasons. First, Rpb7p is involved in the major deadenylation-
dependent decay pathways; these pathways operate in the cyto-
plasm (Coller and Parker, 2004; Amrani et al., 2006; Garneau 
et al., 2007). Second, Rpb7p is a constituent of PBs, which are 
cytoplasmic loci where mRNA decapping and degradation are 
performed, and Rpb7p is a functional effector of PBs. Third, 
Rpb7p interacts with components of the Pat1p/Lsm1-7 complex, 
known to be involved in the cytoplasmic decay pathway (Coller 
and Parker, 2004; Amrani et al., 2006; Garneau et al., 2007). Last, 
Rpb7p is required for 3′ to 5′ degradation of MFA2pG fragment. 
Because this fragment is the product of Xrn1p that acts in the 
cytoplasm (Coller and Parker, 2004; Amrani et al., 2006; Garneau 
et al., 2007), the stimulation of the 3′ to 5′ fragment degradation 
by Rpb7p must occur in the cytoplasm.
Rpb7p functions in mRNA decay in the 
context of the Rpb4/7 heterodimer, but 
performs a role distinct from Rpb4p
Several observations have led us to propose that Rpb7p role 
in mRNA decay, at least in the decay of some mRNAs, is per-
formed in the context of Rpb4/7. First, Rpb4p and Rpb7p shut-
tle between the nucleus and the cytoplasm as a heterodimer 
(Selitrennik et al., 2006), suggesting that their role in the cytoplasm 
is also performed in the context of the heterodimer. Compromising 
this interaction by mutating Rpb7p (e.g., in rpb7-29 cells) slows 
down import of both partners to the nucleus (Selitrennik et al., 
2006). Second, both proteins interact with Pat1p and Lsm2p, but 
not with other known decay factors. Third, overexpression of 
both RPB4 and RPB7, but not one of them at a time, has a strong 
suppressive effect on the ts phenotype of a pat1∆ mutant. Fourth, 
both proteins are colocalized in the same PBs. It is worth noting, 
however, that we have observed cases in which Rpb4p-containing 
foci were not colocalized with Rpb7p-containing ones, and vice 
versa. Last, RPB4, which is otherwise a nonessential gene, is 
synthetically lethal with the rpb7 alleles whose products are 
specifi  cally defective in mRNA decay (Fig. S4).
Unlike the infl  uence of Rpb4p on mRNA decay that is 
limited to PBF mRNAs (Lotan et al., 2005), Rpb7p appears to 
play a more general role in mRNA decay. It is important to 
emphasize that Rpb7p can function normally in the decay of 
several non-PBF mRNAs (e.g., MFA2, ACT1 mRNAs) in the 
absence of Rpb4p (Lotan et al., 2005). We propose that Rpb7p 
plays at least two roles in mRNA decay, only one of which (and 
not necessarily in all cases) involves recruiting Rpb4p. Further-
more, only in the case of PBF mRNA degradation, is this re-
cruitment functionally important. Thus, each partner contributes 
differently to the mRNA decay pathway. We fi  nd that both pro-
teins interact with the basal decay factor Pat1p/Lsm1-7p via di-
rect interactions with Pat1p and Lsm2p. However, the two-hybrid 
approach cannot indicate the relative contribution of each part-
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both proteins has a synergistic effect on genetic interactions 
with PAT1, it is likely that each protein contributes to the capac-
ity of the heterodimer to recruit the Pat1p/Lsm1-7p complex. 
Thus, it is not likely that the interaction of the heterodimer with 
Pat1p/Lsm1-7p accounts for the specifi  c role of Rpb4p in the 
decay pathway of PBF mRNAs. Therefore, we posit that there 
may exist other partners that interact specifi  cally with Rpb4p or 
with Rpb7p that are required for modulating mRNA decay. 
For example, we propose that Rpb4p specifi  cally interacts with a 
factor that modulates the decay of the very unstable PBF mRNAs. 
This scenario can explain why overexpression of RPB7 cannot 
correct the abnormally slow decay kinetics of PBF in rpb4∆ 
cells (Lotan et al., 2005), reinforcing the different functions of 
the two partners in mRNA decay. A search for these putative 
factors is underway.
The role of the Rpb7p–Pat1/Lsm1-7 
interaction
Rpb7p interacts with Pat1p and (to a lesser extent) with Lsm2p, 
two subunits of a key factor in the 5′ to 3′ mRNA decay path-
way, the Pat1/Lsm1-7 complex. It is likely that this interaction 
represents one way that Rpb7p functions in mRNA decay, as 
defects in this interaction correlate with defective mRNA decay. 
The Rpb7p–Pat1p interaction might be important for recruiting 
the Pat1/Lsm1-7 complex to the mRNP, as Rpb7p is among the 
fi  rst proteins that interact with Pol II transcripts (Orlicky et al., 
2001; Meka et al., 2003, 2005; Ujvari and Luse, 2006). Alterna-
tively, interaction of Pat1p with Rpb7p might be required for 
subsequent Pat1p activity. Rpb7p may activate the capacity of 
Pat1/Lsm1-7 to stimulate decapping or may direct the complex 
to appropriate locations within the mRNP complex or the mRNA 
sequence. Further experiments are required to obtain detailed 
mechanistic understanding of the role of the Rpb7p-Pat1/Lsm1-7 
interaction in mRNA decay.
rpb7 ts mutant cells effi  ciently recruit Pat1p to PBs at the 
permissive temperatures and this Pat1p does not dissociate from 
PBs after shifting to the nonpermissive temperature. We inter-
pret these results to indicate that once bound to the mRNP at the 
permissive temperature, Pat1p does not dissociate from mRNP 
even if its association with Rpb7p is diminished. Like Dhh1p-
GFP–containing PBs, Pat1p-GFP–containing PBs do not dis-
appear rapidly during HS in the mutant cells, probably because 
mRNAs are degraded slowly.
Possible cross talk between mRNA 
degradation and transcription
The transcription and mRNA decay machineries are equally 
  responsible for setting the mRNA steady-state levels; however, 
probable communication between these two processes has 
yet to be characterized. Being both Pol II subunits and mRNA 
decay factors, Rpb4p and Rpb7p represent promising candidates 
for mediators of such cross talk. Two of the four Rpb7p mutants 
that we analyzed in detail are not defective in transcription at 
the nonpermissive temperature (see Fig. S2). This suggests that 
the functions of Rpb7p in transcription and in mRNA decay can 
be uncoupled. It remains to be determined whether the nuclear 
and the cytoplasmic roles of Rpb4p and Rpb7p are related, and 
whether the two proteins are involved in any dialogue between 
mRNA synthetic and decay machineries.
Materials and methods
Yeast strains and plasmids
Yeast strains are listed in Table I. pMC116 is a high copy (2μ) plasmid 
carrying RPB7 under its own natural promoter bordered by NotI–HapI 
sites. pMC257 is a HIS3 CEN derivative of pMC116. pRPB4 2μ is a high 
copy plasmid and was described previously as pMC4 2μ (Choder, 1993). 
To construct pRPB4/7 2μ, a fragment containing RPB7 including 428 bp 
of the 5′ noncoding region and 436 bp of the 3′ noncodong region was 
inserted into SacII–BamHI sites of pRPB4 2μ.
Creating temperature-sensitive (ts) rpb7 mutants
RPB7 was mutagenized randomly, using a PCR mutagenesis scheme as de-
scribed previously (Farago et al., 2003), using oMC367 (5′-G  C  A  T  G  C  A  T-
G  T  G  C  T  C  T  G  T  A  T  G  -3′) and oMC368 (5′-G  T  T  A  C  A  T  G  C  G  T  A  C  A  C  G  C  G  -3′) 
with pMC116 as the template. Both primers recognize vector sequences 
ﬂ  anking RPB7, which are identical in pMC116 and pMC257. The muta-
genized rpb7-containing fragment was inserted into NotI–HapI-linearized 
pMC257 by cotransformation in yMC140. pRPB7::URA3 present in yMC140 
was evicted using 5-ﬂ  uoroorotic acid (5-FOA) to select for cells that lose 
URA3, resulting in cells that carry only the mutagenized rpb7 whose tran-
scription is controlled by RPB7 promoter. 5-FOA selection was done twice. 
5-FOA–resistant strains were allowed to form colonies at 30 and 37°C. 
Mutants unable to form colonies at 37°C were selected.
Determining synthetic lethality between rpb7 ts and XRN1
XRN1 was deleted from a strain whose sole Rpb7p was expressed from a 
RPB7::URA3 plasmid to create yMC414. Next, yMC414 was transformed 
with HIS3 plasmid carrying RPB7 or mutant rpb7. Transformants were 
spotted in a tenfold serial dilution (starting with 10
5 cells per spot) on a 
5-FOA–containing plate (this drug kills cells expressing URA3). Plates were 
incubated at 30°C for 3 d. In case of synthetic lethality, cells could not lose 
pRPB7::URA3 and died. Note that all our rpb7 mutants can proliferate well 
at 30°C if XRN1 is present (see previous section).
Determining mRNA levels and mRNA degradation proﬁ  le
To rapidly inactivate Rpb7p ts forms and simultaneously block transcription 
of non-HS genes, we shifted cells from 30°C (the permissive temperature) 
to 42°C. Northern analysis was done as described previously (Choder, 
1991). mRNA decay assays were done as described previously (Lotan 
et al., 2005). The speciﬁ  c probe of MFA2pG mRNA was prepared as 
follows: MFA2pG was cut with BamH1 (56 bp upstream of (G)18). oMC609 
(A  A  T  G  A  A  A  G  G  G  T  A  G  A  T  A  T  T  G  A  T  T  ) was used in a primer extension reaction 
in the presence of 20 μCi of radiolabled dATP. The resulting fragment was 
108 bases (the poly(G) was in the middle). This fragment was hybridized 
at high stringency as previously published (Choder, 1991), except that the 
hybridization temperature was 72°C. Membrane was then washed at 75°C. 
Under these conditions, the natural MFA2 mRNA is undetected.
Fluorescent microscopy
Images of GFP-containing cells suspended in water were acquired with 
Nikon ACT-1, using a Nikon Eclipse E400, with Nikon Plan Apo 100/1.40 
oil objective. They were collected at room temperature as 1280 × 1024-
pixel ﬁ  les with a digital camera (DXM 1200F; Nikon).
Two-hybrid assay
The bait RPB7-AD or AD tagged rpb7 mutants were constructed according 
to Uetz et al. (2000). A two-hybrid interaction was determined by growth 
on plates lacking leucine, tryptophane, adenine, and histidine, supple-
mented with 5 mM 3-amino-1,2,4-triazole and also by β-gal liquid test, as 
reported previously (Uetz et al., 2000).
Online supplemental material
Fig. S1 shows the sequence of the Rpb7p mutant forms. Fig. S2, transcrip-
tion capacity of rpb7 mutants at 42°C. Fig. S3, decay of Tet-Off-MFA2 at 
37°C. Fig. S4, deletion of RPB4 displays synthetic lethality in combina-
tion with rpb7 ts alleles. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200701165/DC1.
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Table I. Yeast strains used in this study
Strain Genotype Origin
yMC140 MATa rpb7∆::LEU2 ura3-52 his3∆200 leu2-3,112 lys2∆201 ade2 pURA3/CEN/RPB7 (McKune et al., 1993)
yMC229 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 EUROSCARF
yMC269 MATa, can1-100 ade2 his3-11,15 leu2-3,112 trp1-1 ura3-1 This work
yMC272 MATα, pat1::TRP lys2 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 This work
yMC363 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ∆pat1::KanMX4 EUROSCARF
yMC414 MATa, rpb7∆::LEU2 ura3, his3∆200, leu2-3,112, lys ∆201, ade2, xrn1∆::KanMX4 pURA3/CEN/RPB7 This work
yMC436 MATa rpb7∆::LEU2 rpb4∆::KAN ura3-52 his3∆200 leu2-3,112 lys2∆201 ade2 pURA3/CEN/RPB7 This work
yMS8 MATa, his3, leu2, ura3 rpb4∆::HIS3 RPB7-GFP::HIS3X6 pURA3/CEN/RPB4-RFP (Selitrennik et al., 2006)
yRL11 MATa, his3∆1, leu2∆0, met15∆0, ura3∆0 RPB7-GFP::HIS3X6 pURA3/CEN/DCP2-RFP This work
yRL26 MATa, rpb7∆::LEU2 ura3-52, his3∆200, leu3-3,112, lys2∆201, ade2, pHIS3/CEN/rpb7-26 This  work
yRL28 MATa, rpb7∆::LEU2 ura3-52, his3∆200, leu3-3,112, lys2∆201, ade2, pHIS3/CEN/rpb7-28 This  work
yRL29 MATa, rpb7∆::LEU2 ura3-52, his3∆200, leu3-3,112, lys2∆201, ade2, pHIS3/CEN/rpb7-29 This  work
yRL34 MATa, rpb7∆::LEU2 ura3-52, his3∆200, leu3-3,112, lys2∆201, ade2, pHIS3/CEN/rpb7-34 This  work
yRL53 MATa, rpb7∆::LEU2 ura3-52, his3∆200, leu3-3,112, lys2∆201, ade2, pHIS3/CEN/RPB7 This work
yRL72 MATa rpb7∆::LEU2 ura3-52 his3∆200 leu2-3,112 lys2∆201 ade2 PAT1-GFP:: HIS3X6 pHIS3/
 CEN/rpb7-34-RFP 
This work
yRL74 MATa rpb7∆::LEU2 ura3-52 his3∆200 leu2-3,112 lys2∆201 ade2 PAT1-GFP:: HIS3X6 pHIS3/
 CEN/rpb7-28-RFP 
This work
yRL78 MATa rpb7∆::LEU2 ura3-52 his3∆200 leu2-3,112 lys2∆201 ade2 PAT1-GFP:: HIS3X6 pHIS3/
 CEN/RPB7-RFP
This work
yRL93 MATa rpb7∆::LEU2 ura3-52 his3∆200 leu2-3,112 lys2∆201 ade2 pHIS3/CEN/RPB7-RFP 
 pURA3/CEN/DHH1-GFP
This work
yRL95 MATa rpb7∆::LEU2 ura3-52 his3∆200 leu2-3,112 lys2∆201 ade2 pHIS3/CEN/rpb7-28-RFP 
 pURA3/CEN/DHH1-GFP
This work
yRL97 MATa rpb7∆::LEU2 ura3-52 his3∆200 leu2-3,112 lys2∆201 ade2 pHIS3/CEN/rpb7-34-RFP 
 pURA3/CEN/DHH1-GFP
This work
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